Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD22 | P20273 | 6/20 | 0.35 |
| ▸ | MAG | P20916 | 1/20 | 0.35 |
| ▸ | NEU4 | Q8WWR8 | 1/20 | 0.34 |
| ▸ | NEU1 | Q99519 | 1/20 | 0.34 |
| ▸ | NEU3 | Q9UQ49 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30732532 | 1.00 | CD22 (0.35) | CD22MAGNEU4NEU1NEU3 | |
| SCHEMBL31695107 | 0.93 | NANP (0.34) | CD22MAG | |
| SCHEMBL31695035 | 0.85 | CD22 (0.41) | CD22MAGNEU4NEU3 | |
| SCHEMBL31695307 | 0.82 | CD22 (0.40) | CD22NEU4NEU1NEU3 | |
| SCHEMBL31695040 | 0.78 | CD22 (0.49) | CD22MAG | |
| SCHEMBL31695301 | 0.78 | CD22 (0.32) | CD22 | |
| SCHEMBL26943705 | 0.74 | NANP (0.39) | — | |
| SCHEMBL31695272 | 0.74 | NANP (0.39) | MAG | |
| SCHEMBL31695067 | 0.73 | CD22 (0.34) | CD22MAGNEU4NEU1NEU3 | |
| SCHEMBL16373104 | 0.71 | CD22 (0.56) | CD22MAGNEU1NEU3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250313574-A1 | SIALIC ACID DERIVATIVES AND METHODS OF USING SAME | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2025-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250313574-A1 | SIALIC ACID DERIVATIVES AND METHODS OF USING SAME | NEU1, NEU2, NEU4 | CD22 295/4885MAG 136/4885NEU4 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.